QNRX

Quoin Pharmaceuticals
QNRX

19 hedge funds and large institutions have $12.2M invested in Quoin Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.88M
2
+$1.08M
3
+$1.06M
4
Aberdeen Group
Aberdeen Group
United Kingdom
+$1.02M
5
Millennium Management
Millennium Management
New York
+$1.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$3.05M
WP
2
Woodline Partners
California
$1.15M
SCM
3
Stonepine Capital Management
Oregon
$1.13M
Aberdeen Group
4
Aberdeen Group
United Kingdom
$1.08M
Millennium Management
5
Millennium Management
New York
$1.08M
SC
6
SummitTX Capital
Texas
$935K
BFM
7
Boothbay Fund Management
New York
$863K
ACM
8
ADAR1 Capital Management
Texas
$840K
ACM
9
AIGH Capital Management
Maryland
$712K
RCAP
10
Resolute Capital Asset Partners
Colorado
$433K
SCM
11
Soleus Capital Management
Connecticut
$361K
SAM
12
Simplify Asset Management
Nevada
$252K
CC
13
Centiva Capital
New York
$174K
Morgan Stanley
14
Morgan Stanley
New York
$43.3K
GI
15
GAMMA Investing
California
$30.1K
RhumbLine Advisers
16
RhumbLine Advisers
Massachusetts
$24K
SS
17
SBI Securities
Japan
$3.56K
UBS Group
18
UBS Group
Switzerland
$245
HNB
19
Huntington National Bank
Ohio
$6